Alwin Capital
A specialized investment fund focused on frontier life sciences, founded by a team with two decades of deep experience in China's pharmaceutical industry and extensive backgrounds in both industry and finance.
Alwin Capital is a specialized investment fund focused on frontier areas of life sciences.
The firm's founding team has deep experience in China's pharmaceutical industry spanning two decades, with backgrounds in both industry and finance, and possesses extensive investment research expertise.
Over the past several years, built on professional research, guided by scientific disciplines, and supported by a robust investment research framework and mature portfolio management, Alwin Capital has systematically positioned itself across China's frontier life sciences sectors.
The firm has cultivated multiple important leading companies in gene editing, nucleic acid drugs, cell therapy, molecular diagnostics, and other frontier life science areas. Additionally, at the intersection of innovative technology and life sciences, Alwin Capital has made several notable investments with keen investment judgment.